AT A GLANCE
- First question
- Fine lines, pigment, shadow or puffiness?
- Products
- Confirm the exact variant and total cc
- Recovery
- Bumps, swelling and bruising vary
- Travel
- Leave time for review before flying home
The kind answer: ‘dark circles’ is not one diagnosis
If a friend asked whether an under-eye skin booster would fix tired-looking eyes, the honest answer would start with another question: what is creating the tired look? Fine surface creases, brown pigment, visible vessels, a structural hollow, lower-eyelid fat, fluid retention and skin laxity can overlap. One photograph—or one trending product name—cannot separate them reliably.
A 2026 multispecialty systematic review reached the same practical conclusion. Under-eye concerns are multifactorial, and the useful treatment category changes with anatomy: fillers address selected volume loss, lasers may address selected pigment, vascular or laxity concerns, polynucleotides and microneedling are discussed for texture and fine lines, and surgery may be more appropriate for herniated fat or poor eyelid support.
That does not mean everyone needs one of those treatments. It means a consultation should identify the dominant pattern before discussing an injection. If the concern is allergy-related swelling, dermatitis, infection, sudden one-sided change or a vision symptom, elective aesthetic treatment should wait for medical assessment.
Four patterns that can look similar in a travel selfie
Fine lines change with expression and skin movement. Pigment stays visible even when lighting changes. A hollow creates a shadow that often shifts with the direction of light. Puffiness or a festoon creates a contour rather than simply a darker color. These are observations to describe—not a self-diagnosis—and more than one can be present at the same time.
Bring neutral, unfiltered photographs taken in more than one light and tell the doctor whether the appearance changes in the morning, after allergies, with smiling or after previous filler. Previous tear-trough filler matters because persistent or late swelling can be related to an older HA treatment, even when the injection was not recent.
The goal of this four-pattern check is modest: it helps prevent a texture-focused injectable from being sold as a universal answer for pigment, structural shadow or fluid-related puffiness.
- Fine lines: ask whether the concern is static, expressive or surface dryness.
- Pigment or visible vessels: ask what color and depth the clinician sees.
- Shadow or hollow: ask whether midface structure contributes.
- Puffiness: ask whether an injection could add or prolong swelling.
Where REJURAN Eye and Juvelook Eye enter the conversation
Le Moir's current official menu lists both REJURAN Eye and Juvelook Eye for the eye or neck area. They should not be treated as interchangeable names. REJURAN belongs to the polynucleotide family; the manufacturer's English brochure identifies REJURAN i as an under-eye variant. Juvelook products use a different material and preparation, so the exact vial, reconstitution, amount and proposed layer need their own explanation.
For polynucleotides, the evidence is promising but not definitive. A 2025 systematic review found nine low- or moderate-quality studies involving 219 patients, with varied areas and techniques and limited consensus on optimal use. The newer under-eye review includes polynucleotides among several options, while still emphasizing anatomy and patient selection.
A careful doctor may discuss one of these products for selected texture or fine-line concerns—or recommend skincare, a different treatment, staged assessment or no injection. Neither product should be presented as guaranteed to remove a hollow, eye bag, allergy-related swelling or every type of dark circle.

Swelling and small bumps: plan for the long end, not the shortest promise
Needle marks, tenderness, redness, small raised papules, swelling or bruising can follow an under-eye injectable. The manufacturer's brochure says slight swelling or papules may settle within about 24 hours, but that is not a personal guarantee. Thin eyelid skin can make a small amount of swelling or bruising look more obvious, and individual recovery depends on the product, amount, technique, anatomy and health history.
Ask for the common recovery pattern and the longer reasonable range seen with the exact plan. ‘No downtime’ should not be used to promise that the area will look unchanged for a wedding, passport photograph, work call or overnight flight.
Keep filler safety in a separate, explicit conversation. Tear-trough HA filler is a volume treatment, not the same thing as a skin-quality booster. Published reviews describe bruising, malar edema, contour irregularity and rare vascular complications; the FDA and American Academy of Ophthalmology warn that accidental intravascular filler injection can cause tissue injury or vision-threatening events. Sudden vision change, severe or worsening pain, unusual skin whitening or blue-gray color, weakness, facial drooping or speech difficulty needs immediate medical assessment—not a routine message reply.
How to fit an eye-area treatment around a short Seoul trip
There is no universal ‘safe flight the next morning’ rule for every under-eye product and every patient. The practical problem is distance from the treating clinic: visible swelling can outlast a social schedule, and an unexpected reaction may require in-person review. Tell the doctor your arrival, important events, departure time, hotel area and access to care at home.
For a short visit, an early consultation is more useful than a late impulse booking. It leaves room to postpone if the skin is irritated, to separate a filler question from a skin-booster question, and—if treatment is appropriate—to receive written aftercare and a review plan before departure. The best decision may still be to treat after the trip.
Before leaving, keep the exact product and variant, lot number, total amount, areas treated, date, clinician, clinic contact and urgent-care instructions. Do not stop a prescribed medicine simply to reduce bruising unless the prescribing clinician advises it.

A friendly under-eye consultation checklist
You do not need to choose the syringe before the appointment. Bring the questions below and listen for specific answers. A good explanation should connect your visible concern to the proposed material, amount, technique, recovery window and follow-up plan without promising a universal result.
For a broader ingredient map, continue to our Korean skin-booster guide. If you are comparing product families, read the REJURAN and SKINVIVE guide next. Travelers can also use the three-day Seoul planning guide before combining procedures.
- What is the main pattern: fine lines, pigment, visible vessels, hollow or puffiness?
- What exact product and variant will be opened in front of me?
- How many cc in total, and is that total for both eyes?
- Is the proposed eye-area use consistent with the local label? If not, what uncertainty should I understand?
- Who performs the procedure, at what layer and by which delivery method?
- Could my previous filler, allergies, medicines or recent laser change the plan?
- What visible recovery is common, and what is the longer reasonable range?
- Which symptoms need clinic review, urgent assessment or emergency care?
- How will follow-up work after I leave Korea?
- What reasonable alternatives include waiting or doing nothing?
PRICE CONTEXT · AUGUST 2026
What a fair comparison includes
A like-for-like international comparison requires the same product variant, total 2 cc amount, eye-area plan, session count, injector, tax and follow-up. We did not verify a public US or European listing that matched all of those details, so no overseas average or savings percentage is shown.
| Market | Price | Comparison basis |
|---|---|---|
| United States | No matched public price | Exact REJURAN Eye · 2 cc · both-eye session not verified; availability and regulation differ |
| Europe | No matched 2 cc price | Public listings reviewed used 1 mL or omitted volume, so they were excluded from comparison |
| Le Moir · Seoul | ₩400K(≈ $284) | REJURAN Eye (I/S) · 2 cc · eye or neck · before VAT · current official clinic menu |
The Seoul dollar approximation uses ECB reference rates published 18 August 2026: €1 = $1.1576 and €1 = ₩1,632.30, giving a derived ₩1,410 ≈ $1. Amounts are rounded; card and bank rates vary ECB reference rates.
The Seoul figure is a current clinic list price, not a treatment recommendation. Because no identical US or European basis was matched, it is not presented as cheaper by a percentage. Confirm whether the quoted 2 cc is intended for both eyes, which exact variant will be used, who injects it and what follow-up is included.
COMMON QUESTIONS
Before you book
Can an under-eye skin booster remove every type of dark circle?
No. Pigment, visible vessels, structural shadow, thin skin and puffiness can look similar but need different assessment. A texture-focused injectable should not be promised as a universal correction.
Are REJURAN Eye and Juvelook Eye the same treatment?
No. They are different product families with different materials, preparation and evidence. Confirm the exact variant, amount, local label, proposed layer and reason for choosing it.
Is an under-eye skin booster the same as tear-trough filler?
No. Tear-trough HA filler is used to address selected volume loss. A skin-booster discussion is usually framed around skin quality. Their materials, goals and risk conversations are not interchangeable.
Can I fly the day after an under-eye injection?
There is no universal answer. Swelling, papules or bruising can remain visible, and an unexpected reaction may need an in-person review. Share the exact itinerary and build a follow-up plan before treatment.
How much is REJURAN Eye at Le Moir?
The current official menu lists REJURAN Eye (I/S) 2 cc for the eye or neck at ₩400,000 before VAT. Confirm the exact variant, whether 2 cc is the total for both eyes and what the quote includes.
Which symptoms are not routine after an eye-area injection?
Sudden vision change, severe or worsening pain, unusual white, gray or blue skin, weakness, facial drooping, speech difficulty or another acute neurological symptom requires immediate medical assessment.
SOURCES & FURTHER READING
Check the original information
- PubMed — 2026 systematic review of current under-eye treatments
- PubMed — 2025 systematic review of polynucleotides in aesthetic medicine
- PharmaResearch — official English REJURAN product-family brochure
- Juvelook — official product composition and intended use
- Le Moir Clinic — official skin-booster program and product imagery
- Le Moir Clinic — current official treatment price guide
- US FDA — dermal filler safety and urgent warning signs
- PubMed — American Academy of Ophthalmology report on vision-threatening filler complications
- PubMed Central — infraorbital hollow assessment, complications and midface support
- European Central Bank — euro reference exchange rates
Published August 19, 2026 · Last reviewed for factual accuracy August 19, 2026. Product availability, regulation and clinic pricing can change.


